ExonHit Presents New Clinical Advances on Its Alzheimers Diagnostic Programs
ExonHit Therapeutics has presented clinical data on the validation set Alzheimer patients versus healthy controls for AclarusDx (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimers disease.
Read More